What Trump’s New Pick for A G Means for Cannabis Reform

If you cannot view this email, please click here.

DEA Denies Collusion Allegations Ahead of Cannabis Rescheduling Hearing

The DEA argues that cannabis advocates have no evidence that the agency engaged in unlawful communications with a prohibitionist group.

Smart Approaches to Marijuana Responds to Claims It Colluded With DEA

The prohibitionist group says cannabis rescheduling advocates are attempting to ‘create a sideshow’ of the DEA’s hearing process.

How Trump’s New Attorney General Pick Pam Bondi Might Affect Cannabis Reform

The president-elect plans to nominate Florida’s former attorney general for his cabinet, but she lacks a pro-cannabis record.

7 Critical Questions Cannabis Businesses Need to Be Asking About The Corporate Transparency Act, The Most Important Federal Law You’ve Never Heard Of

Complying with the CTA, which took effect in 2024, can be deceptively complicated, and failure to do so can subject companies to civil—and even criminal—penalties.

Cannabis Rescheduling Judge Says Hands Tied Behind Back, Can’t Add More Participants

The DEA’s administrative law judge said he was 'not involved in or apprised of' the process the agency utilized to select the participants.

Verano Dispensary Workers Ratify Teamsters Union Contract in Illinois

Acreage Expects to be Acquired by Canopy USA in Mid-December

Cannabis Rescheduling Advocates Say DEA Stacked Deck, Colluded With Prohibitionists

Trump Is In: Will Pro-Cannabis Reform Be In or Out?

Is Trump Good for Cannabis? MariMed CEO Explains

Trump’s Pro-Cannabis Pick for Attorney General Withdraws Name

About CBT:
Cannabis Business Times is the most trusted source of actionable intelligence for plant-touching cannabis businesses throughout North America.

To unsubscribe from Cannabis Business Times' email newsletter click here.